Old Web
English
Sign In
Acemap
>
authorDetail
>
Peter McGuirk
Peter McGuirk
Ashford University
Cancer research
Biology
TLR2
Internal medicine
Immunology
3
Papers
89
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Clinical Study of Tomaralimab (OPN-305), a Toll-like Receptor 2 (TLR-2) Antibody, in Heavily Pre-Treated Transfusion Dependent Patients with Lower Risk Myelodysplastic Syndromes (MDS) That Have Received and Failed on Prior Hypomethylating Agent (HMA) Therapy
2018
Blood
Guillermo Garcia-Manero
Elias Jabbour
Marina Konopleva
Naval Daver
Gautam Borthakur
Courtney D. DiNardo
Prithviraj Bose
Parita Patel
Rami S. Komrokji
Aditi Shastri
Gail J. Roboz
Robert M. Miller
Sarah Arbe-Barnes
Mary M. Reilly
Peter McGuirk
Tara Kearney
Brian Keogh
Hagop M. Kantarjian
Show All
Source
Cite
Save
Citations (9)
Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer’s disease
2016
Brain Behavior and Immunity
Claire L. McDonald
Edel Hennessy
Ana Rubio-Araiz
Brian Keogh
William McCormack
Peter McGuirk
Mary Reilly
Marina A. Lynch
Show All
Source
Cite
Save
Citations (46)
1